JP2014527396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527396A5 JP2014527396A5 JP2014509528A JP2014509528A JP2014527396A5 JP 2014527396 A5 JP2014527396 A5 JP 2014527396A5 JP 2014509528 A JP2014509528 A JP 2014509528A JP 2014509528 A JP2014509528 A JP 2014509528A JP 2014527396 A5 JP2014527396 A5 JP 2014527396A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence represented
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161530194P | 2011-09-01 | 2011-09-01 | |
| US61/530,194 | 2011-09-01 | ||
| US201261659637P | 2012-06-14 | 2012-06-14 | |
| US61/659,637 | 2012-06-14 | ||
| PCT/JP2012/072667 WO2013032032A1 (en) | 2011-09-01 | 2012-08-30 | Anti-human xcr1 antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014527396A JP2014527396A (ja) | 2014-10-16 |
| JP2014527396A5 true JP2014527396A5 (enExample) | 2015-10-01 |
| JP5989096B2 JP5989096B2 (ja) | 2016-09-07 |
Family
ID=46881120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509528A Expired - Fee Related JP5989096B2 (ja) | 2011-09-01 | 2012-08-30 | 抗ヒトｘｃｒ１抗体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9371389B2 (enExample) |
| EP (1) | EP2751140B1 (enExample) |
| JP (1) | JP5989096B2 (enExample) |
| KR (1) | KR101767717B1 (enExample) |
| CN (1) | CN103764680B (enExample) |
| AR (1) | AR087749A1 (enExample) |
| AU (1) | AU2012302596B2 (enExample) |
| BR (1) | BR112014004352A2 (enExample) |
| CA (1) | CA2846370C (enExample) |
| ES (1) | ES2684173T3 (enExample) |
| HK (1) | HK1199038A1 (enExample) |
| IL (1) | IL231075A (enExample) |
| IN (1) | IN2014CN01466A (enExample) |
| MX (1) | MX346560B (enExample) |
| MY (1) | MY166152A (enExample) |
| PH (1) | PH12014500384A1 (enExample) |
| RU (1) | RU2619180C2 (enExample) |
| TW (1) | TWI563004B (enExample) |
| WO (1) | WO2013032032A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101641206B1 (ko) * | 2013-06-24 | 2016-07-22 | 에이비엘바이오 주식회사 | 안정성이 개선된 항체-약물 결합체 및 이의 용도 |
| JP7076082B2 (ja) * | 2015-08-05 | 2022-05-27 | アクティコー バイオテック | 新規な抗ヒトｇｐｖｉ抗体およびその使用 |
| CN110494447B (zh) | 2017-02-03 | 2024-06-04 | 艾科迪科尔生物技术公司 | 使用抗人gpv1抗体抑制血小板聚集 |
| EP3580230A1 (en) | 2017-02-07 | 2019-12-18 | VIB vzw | Immune-cell targeted bispecific chimeric proteins and uses thereof |
| CN107312092B (zh) * | 2017-05-04 | 2020-12-11 | 华南农业大学 | 一种斜带石斑鱼ccr12的多克隆抗体制备方法及其应用 |
| WO2019068099A1 (en) * | 2017-09-29 | 2019-04-04 | The Broad Institute, Inc. | METHODS AND COMPOSITIONS FOR MODULATION OF LYMPHOCYTE ACTIVITY SUPPRESSION |
| US20200354424A1 (en) * | 2018-01-26 | 2020-11-12 | Orionis Biosciences, Inc. | Xcr1 binding agents and uses thereof |
| CA3118892A1 (en) | 2018-11-08 | 2020-05-14 | Orionis Biosciences, Inc. | Modulation of dendritic cell lineages |
| CN113412123A (zh) | 2018-12-28 | 2021-09-17 | 豪夫迈·罗氏有限公司 | 用于免疫应答增强的患者的治疗性用途的肽-mhc-i-抗体融合蛋白 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5786210A (en) | 1994-02-08 | 1998-07-28 | Schering Corporation | Mammalian thymokine genes |
| US20030186889A1 (en) * | 2000-03-31 | 2003-10-02 | Wolf-Georg Forssmann | Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| WO2002059608A2 (en) | 2000-11-29 | 2002-08-01 | Lifespan Biosciences, Inc. | Compositions and methods related to chemokine (c motif) xc receptor 1 (ccxcr1) |
| US20050136033A9 (en) * | 2002-08-13 | 2005-06-23 | Matthias Mack | Method of treating allergen induced airway disease |
| WO2004072646A1 (en) * | 2003-02-13 | 2004-08-26 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 5 (gpr5) |
| EP1698902A1 (en) * | 2005-03-01 | 2006-09-06 | DKFZ Deutsches Krebsforschungszentrum | Use of XCR1 for diagnosing or monitoring of immune tolerance |
| CN101293924A (zh) | 2007-04-24 | 2008-10-29 | 上海国健生物技术研究院 | 骨桥蛋白的功能表位、与其特异性结合的单克隆抗体及其在制备抗肿瘤转移药物中的用途 |
| EP2062592A1 (en) * | 2007-11-20 | 2009-05-27 | BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten | System for delivery into a XCR1 positive cell and uses thereof |
| BRPI1008441A2 (pt) | 2009-02-16 | 2016-10-11 | Biolex Therapeutics Inc | anticorpo humanizado, composição farmacêutica, método para tratar e prevenir um distúrbio de célula b em sujeito, composição de anticorpo anti-cd-20 humanizado, ácido nucléico isolado e célula hospedeira. |
-
2012
- 2012-08-30 AR ARP120103217A patent/AR087749A1/es unknown
- 2012-08-30 AU AU2012302596A patent/AU2012302596B2/en not_active Ceased
- 2012-08-30 KR KR1020147004507A patent/KR101767717B1/ko not_active Expired - Fee Related
- 2012-08-30 JP JP2014509528A patent/JP5989096B2/ja not_active Expired - Fee Related
- 2012-08-30 MX MX2014002078A patent/MX346560B/es active IP Right Grant
- 2012-08-30 CA CA2846370A patent/CA2846370C/en not_active Expired - Fee Related
- 2012-08-30 CN CN201280041366.2A patent/CN103764680B/zh not_active Expired - Fee Related
- 2012-08-30 BR BR112014004352A patent/BR112014004352A2/pt not_active Application Discontinuation
- 2012-08-30 HK HK14112359.4A patent/HK1199038A1/xx unknown
- 2012-08-30 PH PH1/2014/500384A patent/PH12014500384A1/en unknown
- 2012-08-30 RU RU2014106832A patent/RU2619180C2/ru not_active IP Right Cessation
- 2012-08-30 ES ES12761822T patent/ES2684173T3/es active Active
- 2012-08-30 US US14/240,090 patent/US9371389B2/en not_active Expired - Fee Related
- 2012-08-30 EP EP12761822.1A patent/EP2751140B1/en not_active Not-in-force
- 2012-08-30 IN IN1466CHN2014 patent/IN2014CN01466A/en unknown
- 2012-08-30 WO PCT/JP2012/072667 patent/WO2013032032A1/en not_active Ceased
- 2012-08-30 TW TW101131633A patent/TWI563004B/zh not_active IP Right Cessation
- 2012-08-30 MY MYPI2014700412A patent/MY166152A/en unknown
-
2014
- 2014-02-20 IL IL231075A patent/IL231075A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527396A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| JP2015535828A5 (enExample) | ||
| RU2571204C3 (ru) | Специфические связывающие агенты против в7-н1 | |
| JP2020023523A5 (enExample) | ||
| JP2016185981A5 (enExample) | ||
| ME03806B (me) | Antitela protiv cd73 i njihova upotreba | |
| JP2013538057A5 (enExample) | ||
| HRP20201375T1 (hr) | ANTI-BCMA ANTITIJELA, BISPECIFIČNI ANTIGEN VEŽUĆE MOLEKULE KOJE SE VEŽU ZA BCMA i CD3, I NJIHOVE UPOTREBE | |
| JP2016196468A5 (enExample) | ||
| JP2014039548A5 (enExample) | ||
| HRP20251181T1 (hr) | Protutijela na protein gprc5d, bispecifične molekule koje vezuju antigen i koje vezuju gprc5d i cd3 te njihove primjene | |
| JP2017530722A5 (enExample) | ||
| AU2016204274A1 (en) | Antibodies that bind to OX40 and their uses | |
| JP2011509245A5 (enExample) | ||
| PH12014501783A1 (en) | Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody | |
| JP2016508496A5 (enExample) | ||
| JP2016507523A5 (enExample) | ||
| RU2017105915A (ru) | Антитела против pd-1 | |
| JP2017052784A5 (enExample) | ||
| FI3525583T3 (fi) | Anti-c1s-vasta-aineita ja niiden käyttömenetelmiä | |
| HRP20240719T1 (hr) | Kimerna i humanizirana monoklonska protutijela protiv ljudskog ctla4 i njihova upotreba | |
| HRP20180147T1 (hr) | Cea protutijela | |
| NZ602892A (en) | Antibodies that bind human cd27 and uses thereof | |
| HRP20192098T1 (hr) | Antitijela na glukokortikoidom inducirani receptor faktora nekroze tumora (gitr) i njihove primjene |